Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of herba rabdosiae to treatment of skin diseases

A skin disease, the technology of Rubescens, applied in the field of pharmaceutical compositions for the treatment of skin diseases related to excessive keratinocyte proliferation, the treatment of skin diseases by Rubescens, and psoriasis

Inactive Publication Date: 2017-08-11
SHENZHEN QINGYAQIRUI BIO TECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are no reports about its therapeutic effect on skin diseases related to keratinocyte hyperproliferation, such as psoriasis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of herba rabdosiae to treatment of skin diseases
  • Application of herba rabdosiae to treatment of skin diseases
  • Application of herba rabdosiae to treatment of skin diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Embodiment 1: the preparation of Radix Grass Extract

[0059] Take 100g of the aerial part of Dongling grass (from Kangmei Pharmaceutical Co., Ltd., batch number: 141009111), dry, pulverize, then add 5 times the mass of 90% ethanol, and soak at 60°C for 3 hours under ultrasonic treatment. Then filter and take the filtrate. Repeat the above soaking and filtering steps 2 times. The filtrates were combined, and ethanol was recovered from the filtrates, and then the residue was concentrated to obtain about 2 g of Oridinus extract in the form of an extract for subsequent studies.

Embodiment 2

[0060] Example 2: Rubescens significantly inhibits the proliferation of keratinocytes

[0061] All cell culture reagents (DMEM, FBS, etc.) were purchased from Gibico; MTT (thiazolium blue) and DMSO were purchased from Sigma; keratinocytes HaCaT cells were purchased from the American Type Culture Collection (ATCC) cell bank (ATCC number: CRL-2310).

[0062] HaCaT cells were seeded on a 96-well plate at 10,000 cells per well, and each well contained DMEM (Dulbecco's modified eagle medium) supplemented with 10% fetal bovine serum (FBS), 100 U / mL penicillin, and 100 mg / mL streptomycin. liquid, in 5% CO 2 and incubated overnight at 37°C. The next day, the DMSO solution of the ethanol extract of Rubescens japonicus was added to different final concentrations (50, 20, 10, 0 μg / mL), and cultured for another 72 hours. Then, 20 μl of 5 mg / mL MTT solution was added to each well, and the incubation was continued for 4 hours. Aspirate the culture solution in the wells to terminate the ...

Embodiment 3

[0064] Example 3: Rubescens significantly inhibits the expression of inflammatory factors in mouse macrophages

[0065] All cell culture reagents (DMEM, FBS, etc.) were from Gibico; reverse transcription kits and real-time fluorescent quantitative PCR (RT-PCR) kits were purchased from Takara; LPS were purchased from Sigma; mouse macrophage RAW 264.7 In the ATCC cell bank (ATCC number: TIB-71 TM ). RAW 264.7 at 5% CO 2 and cultured at 37°C in DMEM (Dulbecco's modified eagle medium) supplemented with 10% fetal bovine serum (FBS), 100 U / mL penicillin, and 100 mg / mL streptomycin.

[0066] RAW 264.7 cells were cultured in a 6-well plate to a density of 60%, and LPS was added to a final concentration (1 μg / mL). For the experimental group, the DMSO solution of the ethanol extract of Rubescens japonicus was added to different final concentrations (50, 20, 10 μg / mL); for the control group, DMSO was added to the final concentration of 1 μg / mL. A blank group was also set up, to which...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of herba rabdosiae to treatment of skin diseases. Specifically, the invention relates to application of herba rabdosiae to preparation of pharmaceutical compositions for treating skin diseases relevant to excessive proliferation of keratinocytes, especially psoriasis.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and relates to the application of Oridonium japonicus in treating skin diseases. Specifically, the present invention relates to the use of Rubescens japonicus in the preparation of a pharmaceutical composition for treating skin diseases associated with excessive proliferation of keratinocytes, especially psoriasis. Background technique [0002] The epidermis is an important barrier to protect the body from external environmental factors. It is composed of two types of cells, keratinocytes and dendritic cells, of which keratinocytes account for more than 80% of the epidermis. Keratinocytes ultimately produce keratin. According to their differentiation stage, keratinocytes can be divided into five layers from deep layer to superficial layer, namely, basal layer, spinous layer, granular layer, transparent layer and stratum corneum. [0003] Hyperproliferation of keratinocytes is the ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/53A61P17/12A61P17/06A61P19/02A61P35/00A61P17/00
CPCA61K36/53A61K2236/333A61K2236/39A61K2236/51
Inventor 朱志远孙海丰张定阳靖燕炜
Owner SHENZHEN QINGYAQIRUI BIO TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com